Silver Book Fact

Following the current path, the lung cancer incidence rate will increase by 34% between 2003 and 2023. If an alternative path is taken, there will be 18.4% (92,000) fewer lung cancer cases in 2023.

DeVol R, Bedroussian A, Charuworn A, et al. An Unhealthy America: The economic burden of chronic disease. The Milken Institute; October 2007. http://www.milkeninstitute.org/publications/publications.taf?function=detail&ID=38801018&cat=ResRep

Reference

Title
An Unhealthy America: The economic burden of chronic disease
Publisher
The Milken Institute
Publication Date
October 2007
Authors
DeVol R, Bedroussian A, Charuworn A, et al
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development that is a monoclonal antibody, targets the epidermal growth factor receptor. Because cancer cells can become…  
  • Death rates from breast cancer declined by an average of 2.3% per year between 1990 and 2002 because of earlier detection through screening, better awareness, and improved treatments.  
  • Medicines in Development for Cancer  
  • Improvement in 5-Year Survival Rates for All Cancers Since 1975
     
  • Medical research that resulted in a 1/5 reduction in deaths from cancer would be worth $10 trillion to Americans-double the national debt.